181 related articles for article (PubMed ID: 12777313)
1. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?
Kokkonen JO; Lindstedt KA; Kovanen PT
Circulation; 2003 May; 107(20):2522-4. PubMed ID: 12777313
[No Abstract] [Full Text] [Related]
2. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
3. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Husain A; Li M; Graham RM
Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
[No Abstract] [Full Text] [Related]
4. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
Roks A; Buikema H; Pinto YM; van Gilst WH
Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
[TBL] [Abstract][Full Text] [Related]
5. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A
J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618
[TBL] [Abstract][Full Text] [Related]
6. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiological roles of human chymase].
Nakayama S; Urata H; Arakawa K
Nihon Rinsho; 1997 Aug; 55(8):1903-8. PubMed ID: 9284400
[TBL] [Abstract][Full Text] [Related]
8. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart.
Katugampola SD; Davenport AP
Clin Sci (Lond); 2002 Jan; 102(1):15-21. PubMed ID: 11749656
[TBL] [Abstract][Full Text] [Related]
9. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
[TBL] [Abstract][Full Text] [Related]
10. Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs.
Jin D; Ueda H; Takai S; Okamoto Y; Muramatsu M; Sakaguchi M; Shibahara N; Katsuoka Y; Miyazaki M
J Am Soc Nephrol; 2005 Apr; 16(4):1024-34. PubMed ID: 15744002
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway?
Kokkonen JO; Saarinen J; Kovanen PT
Ann Med; 1998 Aug; 30 Suppl 1():9-13. PubMed ID: 9800878
[TBL] [Abstract][Full Text] [Related]
13. Cardiac remodeling and angiotensin II-forming enzyme activity of the left ventricle in hamsters with chronic pressure overload induced by ascending aortic stenosis.
Shimizu M; Tanaka R; Fukuyama T; Aoki R; Orito K; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):271-6. PubMed ID: 16598172
[TBL] [Abstract][Full Text] [Related]
14. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
Urata H; Boehm KD; Philip A; Kinoshita A; Gabrovsek J; Bumpus FM; Husain A
J Clin Invest; 1993 Apr; 91(4):1269-81. PubMed ID: 7682566
[TBL] [Abstract][Full Text] [Related]
15. Chymase: a new pharmacologic target in cardiovascular disease.
Bacani C; Frishman WH
Cardiol Rev; 2006; 14(4):187-93. PubMed ID: 16788331
[TBL] [Abstract][Full Text] [Related]
16. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity.
Kokkonen JO; Saarinen J; Kovanen PT
Circulation; 1997 Mar; 95(6):1455-63. PubMed ID: 9118513
[TBL] [Abstract][Full Text] [Related]
17. [involvement of chymase in pathogenesis of cardiovascular diseases].
Urata H
Nihon Rinsho; 2004 Mar; 62 Suppl 3():147-51. PubMed ID: 15171359
[No Abstract] [Full Text] [Related]
18. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
Batlle M; Roig E; Perez-Villa F; Lario S; Cejudo-Martin P; García-Pras E; Ortiz J; Roqué M; Orús J; Rigol M; Heras M; Ramírez J; Jimenez W
J Heart Lung Transplant; 2006 Sep; 25(9):1117-25. PubMed ID: 16962475
[TBL] [Abstract][Full Text] [Related]
19. Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors.
Doggrell SA; Wanstall JC
Can J Physiol Pharmacol; 2005 Feb; 83(2):123-30. PubMed ID: 15791285
[TBL] [Abstract][Full Text] [Related]
20. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
Doggrell SA; Wanstall JC
Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
